Healthcare / Medical Care FacilitiesSES
$0.32
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 26% · confianza 25%
FCF escenarios
weak_data · normalized FCF $5.6M · quality 61.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
49/100
C
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$184M
P/E
16.0x
↓EV/EBITDA
8.1x
↓ROE
13.1%
↑Gross Margin
42.1%
↓Debt/Equity
0.27
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+8.0%
FCF CAGR
—
FCF margin
-0.8%
FCF / Net income
-0.05x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $79.2M · net income $13.4M · FCF $-640000.0
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $79.2M | $79.2M | $74.2M | $70.0M | $63.0M |
| Net Income | $13.4M | $13.4M | $12.8M | $13.0M | $12.5M |
| EBITDA | $23.3M | $23.3M | $22.1M | $21.9M | $20.8M |
| EPS | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| Gross Margin | 42.1% | 42.1% | 44.0% | 44.3% | 45.7% |
| Operating Margin | 22.5% | 22.5% | 24.6% | 26.2% | 28.6% |
| Net Margin | 16.9% | 16.9% | 17.3% | 18.5% | 19.9% |
| Balance Sheet | |||||
| Debt/Equity | 0.27 | 0.27 | 0.15 | 0.16 | 0.17 |
| Current Ratio | 2.38 | 2.38 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-640000.00 | $-640000.00 | $5.6M | $13.7M | $12.1M |
| Returns | |||||
| ROE | 13.1% | 13.1% | 14.2% | 16.1% | 15.7% |
| Valuation | |||||
| P/E | 16.00 | 16.00 | 17.94 | 20.58 | 14.19 |
| EV/EBITDA | 8.06 | 8.06 | 10.28 | 11.89 | 8.21 |
| P/B | 1.81 | 1.81 | 2.56 | 3.30 | 2.22 |
| Growth & Yield | |||||
| Revenue Growth | 6.8% | 6.8% | 6.0% | 11.2% | — |
| EPS Growth | 4.0% | 4.0% | -1.3% | 1.8% | — |
| Dividend Yield | 1.8% | 1.8% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
7.0%
EPS terminal req.
$0.03
Spread vs growth
-2.9%
5Y implied EPS CAGR
8.2%
EPS terminal req.
$0.03
Spread vs growth
-4.1%
10Y implied EPS CAGR
9.1%
EPS terminal req.
$0.06
Spread vs growth
-5.0%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+0.3%
Start / end P/E
14.6x → 13.8x
EPS bridge
0.02 → 0.02
Residual
-0.2%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.